Thermo Fisher Scientific Inc., and Olink Holding AB, a provider of next-generation proteomics solutions, reported that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million. The transaction is expected to be completed by mid-2024. Olink offers solutions for advanced proteomics discovery and development, enabling biopharmaceutical companies...